BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30575304)

  • 1. How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
    Blindbaek SL; Peto T; Grauslund J
    Acta Ophthalmol; 2019 Jun; 97(4):339-346. PubMed ID: 30575304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema.
    Javanović S; Canadanović V; Sabo A; Grgić Z; Mitrović M; Rakić D
    Vojnosanit Pregl; 2015 Oct; 72(10):876-82. PubMed ID: 26665553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema.
    Moisseiev E; Abbassi S; Thinda S; Yoon J; Yiu G; Morse LS
    Eur J Ophthalmol; 2018 Jan; 28(1):68-73. PubMed ID: 28731494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis.
    Wu Y; Ai P; Ai Z; Xu G
    Biomed Pharmacother; 2018 Jan; 97():293-299. PubMed ID: 29091878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injections and diabetic macular edema: actual and new therapeutic options.
    Pescosolido N; Pranno F; Buomprisco G
    Curr Diabetes Rev; 2013 Nov; 9(6):491-8. PubMed ID: 24160355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Macular Edema: Traditional and Novel Treatment.
    Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
    Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection.
    Takamura Y; Tomomatsu T; Matsumura T; Arimura S; Gozawa M; Takihara Y; Inatani M
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4741-6. PubMed ID: 25028357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
    Tai F; Nanji K; Garg A; Zeraatkar D; Phillips M; Steel DH; Garg SJ; Kaiser PK; Guymer RH; Wykoff CC; Sivaprasad S; Chaudhary V
    Ophthalmol Retina; 2024 Mar; 8(3):223-233. PubMed ID: 37805099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema.
    Sivaprasad S; Dorin G
    Expert Rev Med Devices; 2012 Mar; 9(2):189-97. PubMed ID: 22404779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment approaches in diabetic macular edema.
    Meyer CH
    Ophthalmologica; 2007; 221(2):118-31. PubMed ID: 17380066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold micropulse diode laser treatment in diabetic macular edema: biological impact, therapeutic effects, and safety.
    Mei JH; Lin Z
    Int Ophthalmol; 2024 Feb; 44(1):3. PubMed ID: 38315299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema.
    Lee SJ; Kim ET; Moon YS
    Korean J Ophthalmol; 2011 Oct; 25(5):299-304. PubMed ID: 21976935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for diffuse diabetic macular edema.
    Bandello F; Iacono P; Battaglia Parodi M
    Eur J Ophthalmol; 2011; 21 Suppl 6():S45-50. PubMed ID: 23264328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Diabetic Macular Edema.
    Kim EJ; Lin WV; Rodriguez SM; Chen A; Loya A; Weng CY
    Curr Diab Rep; 2019 Jul; 19(9):68. PubMed ID: 31359157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic macular edema: Evidence-based management.
    Browning DJ; Stewart MW; Lee C
    Indian J Ophthalmol; 2018 Dec; 66(12):1736-1750. PubMed ID: 30451174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.